First Light Asset Management, LLC 13F holdings
First Light Asset Management, LLC reported 31 positions with a total reported value of $1.6B as of 2026-06-30, in its 13F for Q2 2026, filed 2026-08-14. Top holdings by reported value: NEO NEOGENOMICS INC (10.9%), SIBN SI-BONE INC (8.1%), AXGN AXOGEN INC (7.7%), APGE APOGEE THERAPEUTICS INC (7.5%), PVLA PALVELLA THERAPEUTICS INC (7.2%). Against 2026-03-31 it opened 2 new positions and exited 6. Next 13F due by 2026-11-14, the legal deadline 45 days after the quarter ending 2026-09-30.
Email me when First Light Asset Management, LLC files its 13F
A free account follows up to 10 funds. New 13F filings arrive in your daily or weekly digest. No password and no card.
Top holdings
25 largest of 31 positions · reported value as of 2026-06-30
| Holding | Shares | Reported value | % of portfolio |
|---|---|---|---|
| NEO NEOGENOMICS INC | 12,279,523 | $179.2M | 10.9% |
| SIBN SI-BONE INC | 8,127,985 | $132.6M | 8.1% |
| AXGN AXOGEN INC | 2,748,361 | $126.9M | 7.7% |
| APGE APOGEE THERAPEUTICS INC | 930,289 | $123.5M | 7.5% |
| PVLA PALVELLA THERAPEUTICS INC | 771,901 | $118.0M | 7.2% |
| TWST TWIST BIOSCIENCE CORPORATION | 727,933 | $74.9M | 4.6% |
| ELVN ENLIVEN THERAPEUTICS INC | 1,360,750 | $69.1M | 4.2% |
| GH GUARDANT HEALTH | 441,586 | $66.3M | 4.0% |
| MASS 908 DEVICES INC | 6,282,804 | $54.7M | 3.3% |
| AMLX AMYLYX PHARMACEUTICALS INC | 3,023,256 | $54.3M | 3.3% |
| WGS GENEDX HOLDINGS CORP | 783,923 | $53.8M | 3.3% |
| SLP SIMULATIONS PLUS INC | 2,792,677 | $51.1M | 3.1% |
| TNDM TANDEM DIABETES CARE INC | 3,383,553 | $51.1M | 3.1% |
| CRNX CRINETICS PHARMACEUTICALS INC | 1,360,866 | $50.9M | 3.1% |
| NPCE NEUROPACE INC | 2,861,167 | $45.5M | 2.8% |
| EWTX EDGEWISE THERAPEUTICS INC | 1,095,171 | $44.5M | 2.7% |
| ANAB ANAPTYS BIO INC | 582,004 | $39.3M | 2.4% |
| TRVI TREVI THERAPEUTICS INC | 2,097,215 | $39.1M | 2.4% |
| SEPN SEPTERNA INC | 963,260 | $32.3M | 2.0% |
| TLSI TRISALUS LIFE SCIENCES INC | 6,552,491 | $29.8M | 1.8% |
| TECX TECTONIC THERAPEUTICS INC | 800,726 | $27.5M | 1.7% |
| HCAT HEALTH CATALYST INC | 12,810,861 | $25.5M | 1.5% |
| BFLY BUTTERFLY NETWORK INC | 2,642,404 | $22.2M | 1.4% |
| ESTA ESTABLISHMENT LABS HOLDINGS | 246,577 | $21.2M | 1.3% |
| PCVX VAXCYTE INC | 345,157 | $20.1M | 1.2% |
SEC FORM 13F · Q2 2026 · VALUES AS REPORTED, NOT PRICES
New positions this quarter
Held at 2026-06-30, not at 2026-03-31 · 2 in all · reported value as of 2026-06-30
Sold out
Held at 2026-03-31, gone by 2026-06-30 · 6 in all · reported value as of 2026-03-31
| Holding | Shares 2026-03-31 | Reported value | % of portfolio then |
|---|---|---|---|
| CENTESSA PHARMACEUTICALS LIMITED | 1,560,991 | $62.0M | 5.6% |
| WVE WAVE LIFE SCIENCES LTD | 1,843,968 | $13.4M | 1.2% |
| VERA VERA THERAPEUTICS INC | 313,906 | $12.6M | 1.1% |
| MDXG MIMEDX GROUP INC | 2,842,892 | $11.2M | 1.0% |
| SGP SPYGLASS PHARMA INC | 375,000 | $9.7M | 0.9% |
| ORGO ORGANOGENESIS HOLDINGS INC | 3,498,533 | $8.3M | 0.7% |
Biggest increases and decreases
Positions held at both quarter ends, by change in shares · reported value as of 2026-06-30
Increases
| Holding | Shares 2026-03-31 | Shares 2026-06-30 | Change | Reported value |
|---|---|---|---|---|
| ELVN ENLIVEN THERAPEUTICS INC | 201,867 | 1,360,750 | +574.1% | $69.1M |
| APGE APOGEE THERAPEUTICS INC | 576,684 | 930,289 | +61.3% | $123.5M |
| SIBN SI-BONE INC | 5,353,190 | 8,127,985 | +51.8% | $132.6M |
| NEO NEOGENOMICS INC | 9,729,978 | 12,279,523 | +26.2% | $179.2M |
| WGS GENEDX HOLDINGS CORP | 242,927 | 783,923 | +222.7% | $53.8M |
| TNDM TANDEM DIABETES CARE INC | 1,314,715 | 3,383,553 | +157.4% | $51.1M |
| GH GUARDANT HEALTH | 280,299 | 441,586 | +57.5% | $66.3M |
| PCVX VAXCYTE INC | 141,784 | 345,157 | +143.4% | $20.1M |
| CRNX CRINETICS PHARMACEUTICALS INC | 1,089,670 | 1,360,866 | +24.9% | $50.9M |
| SEPN SEPTERNA INC | 732,860 | 963,260 | +31.4% | $32.3M |
| TLSI TRISALUS LIFE SCIENCES INC | 5,066,827 | 6,552,491 | +29.3% | $29.8M |
| NPCE NEUROPACE INC | 2,459,966 | 2,861,167 | +16.3% | $45.5M |
Decreases
| Holding | Shares 2026-03-31 | Shares 2026-06-30 | Change | Reported value |
|---|---|---|---|---|
| AXGN AXOGEN INC | 4,002,768 | 2,748,361 | -31.3% | $126.9M |
| PVLA PALVELLA THERAPEUTICS INC | 980,758 | 771,901 | -21.3% | $118.0M |
| TWST TWIST BIOSCIENCE CORPORATION | 878,848 | 727,933 | -17.2% | $74.9M |
| ESTA ESTABLISHMENT LABS HOLDINGS | 307,738 | 246,577 | -19.9% | $21.2M |
| ATRC ATRICURE INC | 729,521 | 567,838 | -22.2% | $15.9M |
| AMLX AMYLYX PHARMACEUTICALS INC | 3,190,645 | 3,023,256 | -5.2% | $54.3M |
| KRMD KORU MEDICAL SYSTEMS INC | 3,768,380 | 3,387,902 | -10.1% | $14.2M |
| OMCL OMNICELL INC | 489,846 | 452,324 | -7.7% | $18.8M |
| RYTM RHYTHM PHARMACEUTICALS INC | 87,181 | 85,765 | -1.6% | $9.5M |
| BFLY BUTTERFLY NETWORK INC | 2,660,167 | 2,642,404 | -0.7% | $22.2M |
| HCAT HEALTH CATALYST INC | 12,878,700 | 12,810,861 | -0.5% | $25.5M |
| IRTC IRHYTHM TECHNOLOGIES | 168,116 | 167,092 | -0.6% | $19.9M |
CIK 1600004 · 13F FILINGS ON EDGAR · INFORMATIONAL ONLY
